Aurinia Pharmaceuticals Inc.

AUPH | NASDAQ

Price Alert Chart Builder DCF Calculator

$16.72

+$0.11 (+0.66%)

Sep 22, 2026, 2:05 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ABCL AbCellera Biologics	N/A
BHVN Biohaven	N/A
CLDX Celldex Therapeutics	N/A
HRMY Harmony Biosciences	N/A
IMCR Immunocore plc	N/A
JANX Janux Therapeutics	N/A
MNKD MannKind	N/A
NUVB Nuvation Bio	N/A
STOK Stoke Therapeutics	N/A
VERA Vera Therapeutics	N/A

Dividend Rankings ➞

Recent News

1 month ago / zacks.com
Aurinia Settles Voclosporin Patent Litigation With Teva, Stock Rises
1 month ago / benzinga.com
Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug
1 month ago / businesswire.com
Aurinia Settles Patent Litigation with Teva
1 month ago / seekingalpha.com
Aurinia Pharmaceuticals Doubles Down On Its Pipeline
2 months ago / zacks.com
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
2 months ago / businesswire.com
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress
3 months ago / businesswire.com
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
3 months ago / zacks.com
Aurinia (AUPH) Upgraded to Strong Buy: Here's Why
3 months ago / zacks.com
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
4 months ago / seekingalpha.com
Aurinia: Cash-Generating Today, Pipeline-Driven Tomorrow